Bollente Companies, Inc. (OTCQB: BOLC), through its trutankless® brand, is a manufacturer and distributor of innovative tankless water heaters in the United States. The company strives to create electric tankless water heaters that far surpass traditional tank water heaters in terms of energy efficiency, output, dependability and environmental sustainability while effectively overcoming the drawbacks of lesser tankless units.

In April, Bollente announced the release of a new line of water heaters geared toward budget-driven customers. These products, known as the Vero™ line, boast the same unrivaled water heating performance, durability and space savings of the trutankless flagship line at a fraction of the cost. Following the enactment of updates to the National Appliance Energy Conservation Act earlier this year, Bollente expects this new product line to provide an opportunity for sustainable market growth in the future.

“The new Department of Energy guidelines for water heaters are going to impact the majority of homes that currently use traditional tank water heaters,” Michael Stebbins, president of trutankless, stated in a news release. “Tanks will become larger and costlier to install, and homes requiring tank heaters that hold 55 or more gallons will have to upgrade to a heat pump for twice the cost, or go tankless. We are pleased to offer whole-home electric tankless solutions that already exceed the new energy factor guidelines.”

The company’s product offerings also include truCirc, a state-of-the-art water circulation pump designed to work seamlessly with its efficient water heaters. truCirc allows users to accurately track water usage throughout their homes and predict when hot water will be needed. By learning usage patterns, the device limits energy usage by keeping water hot only when it is likely to be needed. The product’s intuitive interface also allows homeowners to quickly and easily change delivery modes and zones to minimize wasted water.

“As a standalone product, truCirc provides tremendous energy and water savings for a household,” continued Stebbins. “When used in conjunction with a 99 percent energy-efficient trutankless unit, the end result is a complete water heating system with unrivaled efficiency, durability and long-term value to the homeowner.”

As the home construction industry continues to shift toward more environmentally-friendly solutions, Bollente is in a strong strategic position to record improved financial results. According to a report by McGraw Hill Construction, the overall green single-family housing market is expected to account for more than $80 billion in revenue by 2016, representing a 100 percent increase over the results of 2013. This continued market growth could provide Bollente with an opportunity to post strong results in the future.

Bollente’s proven product line provides the company with a platform to realize continued growth in the months to come. For prospective investors, this growth could translate into sustainable returns moving forward.

For more information, visit www.bollentecompanies.com

BIO-key International, Inc. (OTCQB: BKYI) is a leading provider of advanced fingerprint biometric identification solutions to commercial and government enterprises, integrators and application developers. The company’s award-winning finger identification technology is currently used in some of the world’s largest identification deployments in order to improve security, guarantee identity and reduce identity theft. BIO-key’s software-based products are optimized to deliver fast and accurate user authentication on any device, network or internet environment, giving the company a highly scalable asset to promote future growth.

In March, the company expanded upon its existing product offerings through the announcement of EcoID, a compact USB touch fingerprint reader that delivers top quality identification at an unprecedented price point. With a manufacturer’s suggested retail price that’s substantially lower than other USB touch scanners, BIO-key will look to leverage this product in order to secure a larger share of the touch fingerprint reader market.

In May, BIO-key highlighted an additional, potentially expansive application for its technology when it announced a partnership with HealthCast, Inc. to deliver innovative solutions for single sign-on (SSO) and secure two-factor authentication for electronic prescription of controlled substances (EPCS) to clients across the United States. Potential customers include leading hospitals and hospital systems, such as Rady’s Children’s Hospital in San Diego, California, the first hospital in the country to deploy an EPCS solution utilizing the company’s proprietary EpicCare EMR technology.

“We understand that the doctors and nurses appreciate innovative technology that streamlines what was once a time-consuming and less secure process,” Jim Skidmore, vice president of sales at BIO-key, stated in a news release. “We are pleased to provide our solutions with those of HealthCast to meet these needs.”

Despite a decline in revenue during the first quarter of 2015, BIO-key is in a strong position to capitalize on the wide-spread potential applications of its technology in the months to come. By focusing its sales and marketing efforts on large enterprise and government opportunities, the company will look to achieve vastly increased revenue for the remaining quarters of 2015. In May, BIO-key reported a pipeline of sales opportunities valued at $30 million with which to promote this forecast financial growth.

“We made good progress across the business during the first quarter, helping to solidify our outlook for the balance of 2015 and beyond,” Michael DePasquale, chairman and chief executive officer of BIO-key, stated. “Though our first quarter sales performance fell below last year’s level… we are on target to achieve our full year revenue guidance of five to seven million dollars and expect to demonstrate the strength of our sales effort in our second quarter performance.”

For prospective investors, BIO-key’s recent progress toward expanding the market potential of its innovative biometric technology makes the company an intriguing option to consider moving forward. As it looks to convert upon the massive potential of its sales pipeline, look for BIO-key to take steps toward increasing its share of the domestic security software industry.

For more information, visit www.bio-key.com

DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) is a clinical and commercial stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of cancer. The company’s leading product candidate, VAL-083, is a first-in-class small molecule chemotherapeutic that is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. Previously, the drug candidate has been the subject of extensive research by the U.S. National Cancer Institute, and it is currently approved for the treatment of chronic myelogenous leukemia (CML) and lung cancer in China.

In June, DelMar presented an update on its phase I/II clinical trial of VAL-083, and the initial results provide a promising outlook for the company. Despite having failed prior treatment with standard front-line options and having a growing GBM tumor at the time of enrollment in the DelMar clinical trial, 59 percent of patients treated with VAL-083 recorded better than average survival rates. With proper dosing, an improved median overall survival of about nine months was achieved, which marked a meaningful survival benefit over currently available treatment options.

“The overall survival demonstrated at the higher doses in our clinical trial with only two cycles of treatment is clinically meaningful in comparison to published outcomes in this patient population,” Jeffrey Bacha, president and chief executive officer of DelMar, stated in a news release. “We consider these results to be positive and supportive of the further development of VAL-083 as a potential new therapy for GBM patients who have failed other available treatments.”

In the months to come, DelMar will initiate activities to prepare for advancement to registration-directed phase II/III clinical trials of VAL-083. As the company approaches the eventual commercialization of its drug candidate, early results indicate that it could have the potential to replace temozolomide as the standard of care in newly-diagnosed GBM patients whose tumors express features correlated with resistance to standard chemotherapy.

The potential market for DelMar’s drug candidate upon commercialization with the United States is expansive. According to the American Brain Tumor Association, nearly 700,000 people in the U.S. are currently living with a brain tumor, and nearly 70,000 new cases are diagnosed each year. Among these cases, approximately 17 percent are related to GBM. By providing an improved therapeutic option to temozolomide-resistant GBM, the company is in a strong position to promote sustainable growth moving forward.

For prospective shareholders, DelMar’s continued progress toward the domestic commercialization of VAL-083 makes the company an intriguing investment option in the coming months.

For more information, visit www.delmarpharma.com

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that provide unique and meaningful advantages to patients with renal disease. In December 2014, the company launched its first FDA-approved product, Auryxia™, in the United States for the treatment of elevated serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis. Keryx’s novel treatment is also being commercialized in Japan as Riona® for the treatment of patients with all stages of CKD by the company’s Japanese partner.

According to the National Kidney Foundation, approximately 26 million Americans currently suffer from kidney disease. Among those individuals, approximately 450,000 people are on dialysis treatments. For these people, maintaining serum phosphorus levels is imperative. An additional report by the National Kidney Foundation states that prolonged exposure to elevated phosphorus levels has been shown to cause increases in calcium-phosphate production, which is commonly associated with increased morbidity and, in many cases, mortality. This data highlights the immense market potential of Auryxia moving forward.

In the first quarter of 2015, Keryx leveraged the marketability of its groundbreaking product to record promising financial results. The company reported total revenue of approximately $1.2 million, including both U.S. product revenue and license revenue associated with sales of Riona in Japan. These figures are expected to rise in the future. In June, Keryx announced that Auryxia had been added to the Medicare Part D formularies of two national insurance providers, giving the company access to approximately 65 percent of people in the United States currently taking phosphate binders.

“The inclusion of Auryxia on the major insurance providers’ Part D formularies, which we expect will start processing claims in the third quarter, significantly expands unrestricted access to Auryxia for people on dialysis and their caregivers,” Greg Madison, chief executive officer of Keryx, stated in a news release. “Looking ahead, we are focused on continuing to raise awareness of Auryxia’s clinical profile among the prescribing community and ensuring that the vast majority of dialysis patients have access to this important medicine.”

In addition to plans of adding a team of field sales representatives in the months to come, the company’s short-term objectives include expanding the indication for Auryxia to include the treatment of iron deficiency anemia in patients with CKD. In September 2014, Keryx initiated a phase III study for this indication which is expected to be completed by the end of 2015.

For more information, visit www.keryx.com

Well Power’s attention is firmly on the ways it can help curb the flaring of wasted gas, a persistent and growing problem in the United States. To contribute in this area, the company gained an exclusive license to distribute ME Resources’ micro refinery unit (MRU) years ago and, since then, has been actively promoting this flare-reducing technology to potential investors and other interested parties.

As part of Well Power’s marketing efforts, companies involved in oil and gas production are invited to explore partnership opportunities with Well Power and learn more about the MRU which, once developed, is expected to process and transform wasted raw natural gas into electric power or engineered fuels. Although there are still some operational matters and regulatory changes to study, the successful development and deployment of a mobile, modular micro-refinery unit should create many lucrative opportunities for Well Power and ME Resources.

In addition, Well Power is bringing in new blood to continue to fuel its operations. Early this year, the company expanded its board of directors to include Robert V. Shields, an entrepreneur, professional engineer and petroleum industry veteran. Mr. Shields has been a professional engineer for more than 30 years. His petroleum industry experience is widespread and includes expertise in the areas of drilling, production operations, economic evaluations, identifying and securing international exploration mineral leases as well as raising equity capital from institutional investors in the United States and overseas.

Mr. Shields is a welcome addition to the Well Power team. His early years of employment include tenures with major oil and gas companies including Occidental International. He has extensive cross-cultural management experience as manager of drilling/production operations in Libya, Philippines, Brunei (offshore), the continental USA, Western Canada and the Canadian Arctic. Over 20 years, he also founded and became an owner/partner in four successful private oil companies which have collectively spent $C160 million and accrued a total exit value of approximately $C760 million. Additionally, in 2000, he co-discovered the largest conventional natural gas find in Canada, the Ladyfern field located in NE British Columbia. His combined experience in capital raising, engineering and entrepreneurship within the oil and gas industry will contribute vital insight to Well Power’s corporate goals and mission.

For more information, visit www.wellpowerinc.com

Let us hear your thoughts: Well Power Inc. Message Board

One World Holdings’ subsidiary is preparing to conduct a stockholders conference call next week on Wednesday, July 1 at 11:30 AM ET. The call will deliver an update on the national roll out of product in Wal-Mart Stores (NYSE: WMT) and plans for its business expansion.

Conference call speakers will include Ms. Joanne Melton, One World Holdings CEO and creator of the Prettie Girls! doll line, Ms. Stacey McBride-Irby. The call’s host will be Mr. Trent T. Daniel, Founder of The One World Doll Project.

Due to an anticipated large participant turn out, the call will run in listen-only mode. Those who wish to join should dial in at 712-432-0075 pin 278621# no later than 11:28 AM ET on Wednesday, July 1. The call will last approximately 45 minutes and a recording will be posted to the company website after the call.

The company’s thrust into the retail arena is providing OWOO the foundation it needs for generating its revenue base. At the beginning of Q3, the company announced a 532 percent increase in year-over-year revenue for 2014 while its national expansion puts One World in a strategically desirable position to build on this growth for the foreseeable future.

The Prettie Girls!™ represent a collection of fashion play dolls designed to give a sense and look of diversity in culture, style and interest. McBride-Irby, former Mattel® designer known for creating the company’s first African-American doll, designed the Prettie Girls! aimed at a growing market in need of a new type of experience. The Prettie Girls! take on the positive values and attributes that little girls can relate to and associate with.

For more information on the company, visit www.oneworlddolls.com

Let us hear your thoughts: One World Holdings Message Board

On the Move Systems, focused on the development of various technologies across a wide range of industries, today said one industry analyst’s bold prediction on how the continued rise of 3D printing will alter the freight business in OMVS’s favor reaffirms the company’s bullish stance for the long-term growth prospects for its “Uber-for-Trucking” shared economy platform.

The trucking analyst noted that 3D printing’s rapid climb will enable manufacturers to source more of their materials closer to the factory, thus making national truckers more dependent on local freight networks to deliver materials. To thrive in this coming era, the pundit continued, long-haul carriers will need to build and strengthen their networks with smaller, independent truckers.

This prediction holds great promise for OMVS, which is currently building a revolutionary shared economy business model that will enable these national trucking firms to do exactly that, both online and on demand.

Today’s trucking companies rely on technology to maximize profit from their vehicles, and OMVS’s upcoming platform will enable truckers to not only build networks, but maximize equipment utilization, recruit drivers, and effectively price their services.

“It’s a daring prediction, and one that plays directly into our long-term research and due diligence,” OMVS CEO and President Robert Wilson stated in the news release. “Our revolutionary Uber-for-Trucking platform can help long-haul carriers in building their local networks, and aid local truckers in strengthening ties to long-haul carriers wanting access to their market. Those using our service will be in a great position to succeed when this forecast comes to pass. And OMVS will be in a great position to benefit from strong revenues from these users.”

For more information, visit www.onthemovesystems.com

Let us hear your thoughts: On the Move Systems Corp. Message Board

Content Checked Holdings, Inc. (OTCQB: CNCK) caters to the underserved marketplace for people with dietary restrictions and its associated organizations through the continued development and commercialization of the ContentChecked, MigraineChecked and SugarChecked smartphone applications. The company’s innovative apps, which are currently available on both Google Play and the Apple App Store, allow users to scan food products for food allergens and other unwanted ingredients and provides recommendations of alternative products and recipes that fit within the user’s dietary preferences.

“Born from a father’s confusion and frustration about what to feed his daughter and her friends with specific food allergies, Content Checked was founded to design and develop solutions that will positively impact individuals’ health,” Kris Finstad, chief executive officer of Content Checked, stated in a news release. “[W]e see ContentChecked as being a critical tool to newly diagnosed food allergy families just learning to read labels and finding safe foods.”

In recent years, the prevalence of potentially life-threatening food allergies has rapidly increased. According to data from the Centers for Disease Control and Prevention, the occurrence of food allergies and associated anaphylaxis increased by 18 percent between 1997 and 2007. Today, an estimated 12 million Americans suffer from food allergies, including eight percent of all children, based on a study by the Food Allergy Initiative. For Content Checked, these statistics highlight the potentially massive market appeal of its groundbreaking suite of apps moving forward.

Since being founded in 2013, Content Checked has developed a robust database of allergens, migraine triggers and food ingredients that directly correlate with food allergies or other potential health concerns, which forms the basis of its proprietary apps. This database currently features hundreds of thousands of products, and its highly scalable design will allow the company to expand its services into potentially lucrative markets around the country with limited modifications and investment.

In April, Content Checked prepared to build upon the early progress of its product suite by officially going public. This move allowed the company to secure $1.9 million in funding for the continued development and promotion of its apps. In June, Content Checked gave individual investors improved access to trade shares of the company by listing on the OTCQB exchange.

“Meeting the increased compliance and information requirements of OTCQB provides our investors greater confidence in the information disclosed by the company and ensures our commitment to accountability and transparency,” continued Finstad. “We will continue working toward our goals of uplisting in the future to the NASDAQ stock market and growing our business.”

For prospective shareholders, Content Checked represents an opportunity to invest in an early-stage company with near limitless growth potential as the company continues to scale its databases to increase the market appeal of its app suite across the country.

For more information, visit www.contentchecked.com

Today before the opening bell, the Aristocrat Group announced that it plans on promoting its flagship brand in New Orleans at what’s being publicized as the world’s premiere cocktail festival.

Named “Tales of the Cocktail,” this five-day event in July is full of seminars, tastings, networking and promotion that bring together the international spirits industry to examine top trends and the future of the business. For the first time, RWB Vodka will have its own booth at the festival, exposing the made-in-the-U.S.A. vodka to vendors, distributors and bartenders from around the country and beyond.

“We’re thrilled to be a part of such a large and prestigious gathering, which will be the focus of the entire spirits industry for five days,” stated ASCC CEO Robert Federowicz. “This will be an especially significant event for our company as we work to secure distribution for RWB Vodka in the state of Louisiana.”

ASCC has enjoyed consistent growth since the debut of its flagship product. Following a dedicated, nationwide marketing push that has included tasting tours, sports sponsorships and artist endorsements, the company has built considerable momentum heading into the summer. In April, the company celebrated a new all-time high in total sales of RWB Vodka, and expects the numbers for May to be even better once they’re released.

RWB Handcrafted Ultra-Premium Vodka is currently available at hundreds of retail locations and online, with talks underway to make the brand available in Canada and Mexico. Soon, the company plans to boost its business dramatically by unveiling a new brand this year poised to offer consumers an unprecedented level of convenience—creating a whole new market segment in the process.

For more information on the company, visit www.aristocratgroupcorp.com/investors

Let us hear your thoughts: The Aristocrat Group Corp. Message Board

Purchasing stock confidently requires the right knowledge. As Francis Bacon, the father of the scientific method once stated, “Knowledge is power.”

In mankind’s agricultural past, ownership of land and property meant power. During the Industrial Revolution, ownership of factories and machinery became the basis of wealth and power. Now more than ever, in our globally integrated cybernetic information driven world, knowledge and information in and of itself has become the basis of wealth and power. Examples of those that are powerful due to our current knowledge based society include the wealth of Bill Gates to the influence of the large pharmaceutical companies of which both are based on intellectual property rights.

Control of information is something corporate elites always recognized as a way to consolidate and build wealth and power. In 1983, 90% of American media was owned by 50 companies. Right now, over 90% of the information diet of 313 million Americans is controlled by 6 corporations: News Corporation, Disney, Comcast, Viacom, Time Warner, and CBS. That is 90% of everything Americans see, hear, and consider important. As author Tom Clancy pointed out, those that control the information can control the people. Governments that are despotic have long recognized the importance of controlling the flow of information in a society. For example, China’s government controls its population in part by maintaining massive surveillance and a content control system over their population’s access to the Internet. As elites and governments recognize the importance of controlling knowledge and information, so should you be seeking to build on your sources of information.

Decisions do not happen in a vacuum. They are best made when the individual has sufficient information to weigh the possible consequences of various choices. Access to the right information gives decision-making power, builds your range of options from which to make choices, and is a key step toward empowerment and building wealth. Knowledge gives competence and the capacity to act, and sets one on a path of never ending and self-initiated growth.

One of TraderPower.com’s primary goals is to help investors make the right decisions and discover undervalued stocks poised for exceptional profits. For more information, visit www.TraderPower.com.